期刊文献+

影响肝外胆管癌预后的病理因素分析

Pathological Factors for Prognosis of Extrahepatic Cholangiocarcinoma
下载PDF
导出
摘要 目的探讨肝外胆管癌的病理特征及对其预后的影响。方法回顾性分析2000年1月至2008年4月中国人民解放军空军总医院经手术切除的肝外胆管癌124例,统计病理特点并进行Cox比例风险模型分析和Kaplan-Meier分析其与患者预后的关系。结果 124例肝外胆管癌中位随访时间为75.30月,截至随访终点死亡99例(79.8%)。中位OS 24.47月,1、3和5年生存率分别为77.4%、40.3%和16.9%。结论肿瘤分化程度低、淋巴结有转移、肿瘤有局部浸润、手术切缘有癌细胞浸润是影响肝外胆管癌总生存的风险因素。 Objective To explore the effects of pathological features on the prognosis of extrahepatic cholangiocarcinoma. Methods We analyzed retrospectively 124 patients with extrahepatic cholangiocarcinoma after surgical resection in the Air Force General Hospital, PLA from January 2000 to April 2008 after surgical resection were analyzed retrospectively. The relationship between the pathological features and prognosis was analyzed by Cox proportional hazards model and Kaplan-Meier. Results The median follow-up time of 124 patients with extrahepatic cholangiocarcinoma was 75.30 months and 99 patients(79.8%) died at the end of the follow-up. The median OS was 24.47 months.The 1-, 3- and 5-year survival rates were 77.4%, 40.3% and 16.9%, respectively. Conclusion Low degree of tumor differentiation, lymphatic with metastasis, tumor with local infiltration, surgical edge with tumor cell invasion are risk factors for total survival of extrahepatic cholangiocarcinoma.
出处 《肿瘤防治研究》 CAS CSCD 北大核心 2014年第7期777-780,共4页 Cancer Research on Prevention and Treatment
关键词 肝外胆管癌 预后 病理学 生存分析 Extrahepatic cholangiocarcinoma Prognosis Pathology Survival
  • 相关文献

参考文献10

  • 1Dario Ribero,Marco Amisano,Roberto Lo Tesoriere,Stefano Rosso,Alessandro Ferrero,Lorenzo Capussotti.Additional Resection of an Intraoperative Margin-Positive Proximal Bile Duct Improves Survival in Patients With Hilar Cholangiocarcinoma[J].Annals of Surgery.2011(5)
  • 2Tamara Z. Vern-Gross,Anand T. Shivnani,Ke Chen,Christopher M. Lee,Jonathan D. Tward,O. Kenneth MacDonald,Christopher H. Crane,Mark S. Talamonti,Louis L. Munoz,William Small.Survival Outcomes in Resected Extrahepatic Cholangiocarcinoma: Effect of Adjuvant Radiotherapy in a Surveillance, Epidemiology, and End Results Analysis[J].International Journal of Radiation Oncology Biology Physics.2011(1)
  • 3MasayukiNagahashi,YoshioShirai,ToshifumiWakai,JunSakata,YoichiAjioka,TatsuyaNomura,YoshiakiTsuchiya,KatsuyoshiHatakeyama.Depth of invasion determines the postresectional prognosis for patients with T1 extrahepatic cholangiocarcinoma[J].Cancer.2010(2)
  • 4John W. Nelson,A. Paiman Ghafoori,Christopher G. Willett,Douglas S. Tyler,Theodore N. Pappas,Bryan M. Clary,Herbert I. Hurwitz,Johanna C. Bendell,Michael A. Morse,Robert W. Clough,Brian G. Czito.Concurrent Chemoradiotherapy in Resected Extrahepatic Cholangiocarcinoma[J].International Journal of Radiation Oncology Biology Physics.2009(1)
  • 5Alfredo Guglielmi,Andrea Ruzzenente,Tommaso Campagnaro,Silvia Pachera,Alessandro Valdegamberi,Paola Nicoli,Alessandro Cappellani,Giulio Malfermoni,Calogero Iacono.Intrahepatic Cholangiocarcinoma: Prognostic Factors After Surgical Resection[J]. World Journal of Surgery . 2009 (6)
  • 6Dietmar Tamandl MD,Beata Herberger MSc,Birgit Gruenberger MD,Harald Puhalla MD,Markus Klinger MD,Thomas Gruenberger MD.Influence of Hepatic Resection Margin on Recurrence and Survival in Intrahepatic Cholangiocarcinoma[J].Annals of Surgical Oncology.2008(10)
  • 7Sang Myung Woo MD,Ji Kon Ryu MD,Sang Hyub Lee MD,Ji Won Yoo MD,Joo Kyung Park MD,Yong-Tae Kim MD,Jin-Young Jang MD,Sun-Whe Kim MD,Gyeong Hoon Kang MD,Yong Bum Yoon MD.Recurrence and Prognostic Factors of Ampullary Carcinoma after Radical Resection: Comparison with Distal Extrahepatic Cholangiocarcinoma[J]. Annals of Surgical Oncology . 2007 (11)
  • 8Takahito Nakagawa M.D.,Toshiya Kamiyama M.D.,Nobuaki Kurauchi M.D.,Michiaki Matsushita M.D.,Kazuaki Nakanishi M.D.,Hirofumi Kamachi M.D.,Takeaki Kudo M.D.,Satoru Todo M.D.Number of Lymph Node Metastases Is a Significant Prognostic Factor in Intrahepatic Cholangiocarcinoma[J].World Journal of Surgery.2005(6)
  • 9M. Ducreux,E. Van Cutsem,J.L. Van Laethem,T.M. Gress,K. Jeziorski,P Rougier,T. Wagener,O. Anak,B. Baron,B. Nordlinger.A randomised phase II trial of weekly high-dose 5-fluorouracil with and without folinic acid and cisplatin in patients with advanced biliary tract carcinoma: results of the 40955 EORTC trial[J].European Journal of Cancer.2004(3)
  • 10Tomoki Ebata,Masato Nagino,Junichi Kamiya,Katsuhiko Uesaka,Tetsuro Nagasaka,Yuji Nimura.Hepatectomy With Portal Vein Resection for Hilar Cholangiocarcinoma: Audit of 52 Consecutive Cases[J]. Annals of Surgery . 2003 (5)

共引文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部